Please assess the completion status of the following clinical trial:

Trial Title: Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Operation for rectal cancer or ulcerative colitis an ileostomy (loop or end ileostomy within the last 7 days) OR~* ileostomy patient with contact to the stoma clinic OR~* Short bowel syndrome with a permanent ileostomy~* signed consent form~Exclusion Criteria:~* Complications associated with surgery~* Non-radical surgery~* Chemotherapy~* Poor compliance~* Other serious illness

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Loperamide (Type: ACTIVE_COMPARATOR): Patients will take the drug for three days. Day 1 - uploading with the drug Day 2 - collecting output when necessary Day 3 - radiopaque marker and collection of output every two hours
- Placebo (Type: PLACEBO_COMPARATOR): Patients will take the drug for three days. Day 1 - uploading with the drug Day 2 - collecting output when necessary Day 3 - radiopaque marker and collection of output every two hours

Based on this trial design, predict the completion outcome and termination type (if applicable).